Valuation: Genmab A/S

Market Cap 115B 17.55B 15.35B 14.16B 13.07B 24.81B 1,673B 25.23B 169B 66.42B 824B 65.88B 64.45B 2,834B P/E 2026 *
24.5x
P/E 2027 * 17x
Enterprise Value 134B 20.49B 17.93B 16.53B 15.27B 28.98B 1,955B 29.46B 198B 77.58B 963B 76.95B 75.27B 3,310B EV / Sales 2026 *
4.79x
EV / Sales 2027 * 3.85x
Free-Float
95.41%
Yield 2026 *
-
Yield 2027 * -
1 day-3.19%
Current month+4.09%
1 month+16.20%
3 months+4.39%
6 months-14.37%
Current year-7.82%
1 week 1,807.5
Extreme 1807.5
1,933
1 month 1,549
Extreme 1549
1,933
Current year 1,512
Extreme 1512
2,257
1 year 1,337
Extreme 1337
2,257
3 years 1,157
Extreme 1157
2,814
5 years 1,157
Extreme 1157
3,327
10 years 786.2
Extreme 786.2
3,327
Manager TitleAgeSince
Chief Executive Officer 65 2010-05-31
Director of Finance/CFO 48 2020-02-29
Chief Tech/Sci/R&D Officer - 2024-08-15
Director TitleAgeSince
Director/Board Member 75 2003-10-31
Director/Board Member 58 2014-12-31
Director/Board Member 75 2014-12-31
Date Insider Type Main position Quantity % Market Cap.
11-30Fiscal year

Director

189 0.0003%
11-30Fiscal year

Director

189 0.0003%
11-30Fiscal year

Chairman

378 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-3.19%0.00%+33.99%-26.87% 17.55B
-4.14%-8.06%+57.35%+117.24% 54.63B
+1.84%-0.66%+75.79%+93.87% 54.88B
-2.24%+3.59%+19.60%+466.72% 25.06B
-1.60%-6.21%-19.69%-14.84% 23.14B
+2.43%+1.06%+47.70%-0.11% 19.88B
-6.84%+2.18%+195.12%+357.18% 16.5B
-1.05%+1.16%+25.08%+196.28% 14.2B
+8.74%+3.51%+53.81% - 15.36B
-4.16%+1.63%+70.58%+143.85% 12.37B
Average -1.02%-0.09%+55.93%+148.15% 25.36B
Weighted average by Cap. -1.07%-1.31%+55.80%+138.10%

Financials

2026 *2027 *
Net sales 27.99B 4.28B 3.74B 3.45B 3.19B 6.05B 408B 6.15B 41.26B 16.2B 201B 16.07B 15.72B 691B 32.82B 5.02B 4.39B 4.05B 3.74B 7.1B 479B 7.22B 48.39B 19B 236B 18.85B 18.44B 811B
Net income 4.74B 725M 634M 585M 540M 1.02B 69.11B 1.04B 6.99B 2.74B 34.05B 2.72B 2.66B 117B 7.07B 1.08B 946M 873M 806M 1.53B 103B 1.56B 10.43B 4.1B 50.84B 4.06B 3.97B 175B
Net Debt 19.27B 2.95B 2.58B 2.38B 2.2B 4.17B 281B 4.24B 28.42B 11.16B 139B 11.07B 10.83B 476B 11.76B 1.8B 1.57B 1.45B 1.34B 2.54B 172B 2.59B 17.34B 6.81B 84.51B 6.75B 6.61B 291B
Logo Genmab A/S
Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (83.4%); - income from sales of products (10.7%); - other (5.9%): primarily income from partnership agreement. Net sales are distributed geographically as follows: Denmark (89.4%), the United States (4.9%) and Japan (5.7%).
Employees
3,088
Date Price Change Volume
26-07-10 DKK 1,868.50 -3.19% 189,041
26-07-09 DKK 1,930.00 +2.01% 168,254
26-07-08 DKK 1,892.00 -0.24% 114,880
26-07-07 DKK 1,896.50 +3.78% 119,634
26-07-06 DKK 1,827.50 -2.19% 96,263
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,868.50DKK
Average target price
2,333.28DKK
Spread / Average Target
+24.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GMAB Stock